JILL GILBERT: Open Payments
NPI 1134898943 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,796 in 158 payments from 38 companies in 2025. Trend: 2023 $3,128 · 2024 $3,262 · 2025 $3,796
Food & beverage: $3,311Education: $485
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $363 |
| Janssen Biotech, Inc. | 13 | $323 |
| Astellas Pharma US Inc | 7 | $271 |
| Merck Sharp & Dohme LLC | 8 | $191 |
| SOBI, INC | 3 | $175 |
| Celgene Corporation | 6 | $167 |
| Eisai Inc. | 9 | $163 |
| Gilead Sciences, Inc. | 12 | $158 |
| ABBVIE INC. | 6 | $155 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
Products named: RYBREVANT, REBLOZYL, Lenvima, Trodelvy, KEYTRUDA, KISQALI, Nubeqa, Fabhalta.
Industry payments across FL — which companies pay providers there.
